Mesa, AZ, United States of America

Bereket Zekarias


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bereket Zekarias: Innovator in Immunogenic Compositions

Introduction

Bereket Zekarias is a notable inventor based in Mesa, AZ (US). He has made significant contributions to the field of immunology, particularly through his innovative work involving recombinant bacteria. With a total of 2 patents, Zekarias is recognized for his advancements in creating immunogenic compositions that can effectively induce immune responses.

Latest Patents

Zekarias' latest patents include groundbreaking inventions. The first patent encompasses recombinant bacteria and immunogenic compositions comprising the bacteria. This immunogenic composition is designed to induce an immune response against enteric pathogens. The second patent relates to a recombinant bacterium capable of eliciting an immune response against at least two enteric pathogens, without substantially inducing an immune response specific to the serotype of the bacterium. This invention also includes methods for making such a bacterium, as well as vaccines and methods for utilizing it.

Career Highlights

Zekarias is affiliated with Arizona State University, where he continues to engage in research and development in the field of immunology. His work has the potential to significantly impact public health by providing new methods for combating enteric infections.

Collaborations

Throughout his career, Zekarias has collaborated with esteemed colleagues, including Roy Curtiss III and Kenneth Roland. These partnerships have further enhanced the scope and impact of his research.

Conclusion

In summary, Bereket Zekarias is a distinguished inventor whose work in immunogenic compositions is paving the way for innovative solutions in immunology. His contributions are vital for advancing our understanding and treatment of enteric pathogens.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…